In summary, by analysing the plasma proteomic profiles of different therapeutic responses to glucocorticoids in children with ITP, two important proteins, MYH9 and FETUB, were screened in this study, confirming their role as potential biomarkers of glucocorticoid efficacy in children with ITP. Here, MYH9 is linked to autoimmune thrombocytopenic purpura.